Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

In a new health technology assessment, the U.K. National Institute for Health and Care Excellence (NICE) has voiced misgivings about the evidence behind the use of MRI/ultrasound fusion systems to ...

Pathologic concordance between prostate biopsy and radical prostatectomy improves with use of a novel robotic-assisted transperineal fusion biopsy platform. Optimization of risk stratification at ...

Analysis of false-positive biopsy results of PIRADS 4 lesions in multiparametric magnetic resonance imaging of the prostate: Experience from a single nonacademic center using cognitive fusion.

September is National Prostate Cancer Awareness Month, an important time to bring awareness to prostate health. The prostate gland is a male reproductive organ about the size of a ping-pong ball that ...

A trial found no meaningful difference in detection of clinically significantly prostate cancer between multiparametric MRI-based and microultrasound-based biopsy techniques.

The prostate, a vital part of the male reproductive system, is susceptible to cancer. Prostate cancer is concerning for many men, particularly as they age. It stands as one of the most common cancers ...

The $6m investment expands the group's healthcare portfolio. Boustead Singapore is expanding its healthcare technology ...

Effect of inflammation on prostate cancer incidence and dutasteride efficacy in the Reduction by Dutasteride of Cancer Events (REDUCE) study. Background: PLCO is a large-scale, randomized study to ...